| A must-read roadmap for global biotech leadership. Informed by an international workshop, the report outlines 11 priority actions to scale cell therapies from 100s to 10,000s of doses per year. Cutting through the complexity of process translation, discover how industry insiders are proposing to move the needle in constructive collaboration, automation, digitalisation, and business model innovation. |
